-
1
-
-
84949051186
-
-
Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013
-
Brower, M. (2013) A simple strategy for continuous viral inactivation. Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013.
-
(2013)
A simple strategy for continuous viral inactivation
-
-
Brower, M.1
-
2
-
-
84948995464
-
Continuous processing methods for biological products
-
Patent application WO/2012/078677
-
Ransohoff, T.C. and Bisschops, M.A.T. (2012) Continuous processing methods for biological products. Patent application WO/2012/078677.
-
(2012)
-
-
Ransohoff, T.C.1
Bisschops, M.A.T.2
-
3
-
-
0037224723
-
Virus inactivation in the 1990s - and into the 21st century. Part 4:Culture media, biotechnology products, and vaccines
-
Sofer, G. (2003) Virus inactivation in the 1990s - and into the 21st century. Part 4:Culture media, biotechnology products, and vaccines. BioPharm. Int., 16 (1), 50-57.
-
(2003)
BioPharm. Int.
, vol.16
, Issue.1
, pp. 50-57
-
-
Sofer, G.1
-
4
-
-
0037391331
-
Virus inactivation in the 1990s - and into the 21st century. Part 6:Inactivation methods grouped by virus
-
Sofer, G., Lister, D.C., and Boose, J.A. (2003) Virus inactivation in the 1990s - and into the 21st century. Part 6:Inactivation methods grouped by virus. BioPharm. Int., 16 (4), 42-68.
-
(2003)
BioPharm. Int.
, vol.16
, Issue.4
, pp. 42-68
-
-
Sofer, G.1
Lister, D.C.2
Boose, J.A.3
-
5
-
-
84868158860
-
Integrated continuous production of recombinant therapeutic proteins
-
Warikoo, V. et al. (2012) Integrated continuous production of recombinant therapeutic proteins. Biotechnol. Bioeng., 109, 3018-3029.
-
(2012)
Biotechnol. Bioeng.
, vol.109
, pp. 3018-3029
-
-
Warikoo, V.1
-
7
-
-
84920807117
-
The impact of continuous multicolumn chromatography on biomanufacturing efficiency
-
Bisschops, M. and Brower, M. (2013) The impact of continuous multicolumn chromatography on biomanufacturing efficiency. Pharm. Bioprocess., 1 (4), 361-372.
-
(2013)
Pharm. Bioprocess.
, vol.1
, Issue.4
, pp. 361-372
-
-
Bisschops, M.1
Brower, M.2
-
8
-
-
84949038443
-
-
Biopharmaceutical Manufacturing and Development Summit, Boston, November
-
Noyes, A., Coffman, J., Godavarti, R., and Bisschops, M. (2010) Development of a protein A SMB step for a mAb with up to 10 g/L titers. Biopharmaceutical Manufacturing and Development Summit, Boston, November.
-
(2010)
Development of a protein A SMB step for a mAb with up to 10 g/L titers
-
-
Noyes, A.1
Coffman, J.2
Godavarti, R.3
Bisschops, M.4
-
9
-
-
84949051188
-
-
IBC Biopharmaceutical Manufacturing and Development Conference, San Diego, CA, September 2011
-
Brower, M. (2011) Working towards an integrated antibody purification process. IBC Biopharmaceutical Manufacturing and Development Conference, San Diego, CA, September 2011.
-
(2011)
Working towards an integrated antibody purification process
-
-
Brower, M.1
-
10
-
-
84949051189
-
-
Recovery of Biological Products XIV, Lake Tahoe, August
-
Pieracci, J., Mao, N., Thömmes, J., Pennings, M., Bisschops, M., and Frick, L. (2010) Using simulated moving bed chromatography to enhance hydrophobic interaction chromatography performance. Recovery of Biological Products XIV, Lake Tahoe, August.
-
(2010)
Using simulated moving bed chromatography to enhance hydrophobic interaction chromatography performance
-
-
Pieracci, J.1
Mao, N.2
Thömmes, J.3
Pennings, M.4
Bisschops, M.5
Frick, L.6
-
11
-
-
84949051190
-
-
IBC Single-Use Conference, La Jolla, CA, June 15, 2010
-
Jiang, H. (2010) Purification of H5N1 and H1N1 VLP based vaccines. IBC Single-Use Conference, La Jolla, CA, June 15, 2010.
-
(2010)
Purification of H5N1 and H1N1 VLP based vaccines
-
-
Jiang, H.1
-
12
-
-
84949051191
-
Platform downstream processes in the age of continuous chromatography: a case study
-
Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013
-
Brower, M. (2013) Platform downstream processes in the age of continuous chromatography: a case study. Integrated Continuous Biomanufacturing Conference, Castelldefels, Spain, October 2013.
-
(2013)
-
-
Brower, M.1
-
14
-
-
0035951342
-
Effect of the homogeneity of the column set on the performance of a simulated moving bed unit. I. Theory
-
Mihlbachler, K., Fricke, J., Yun, T., Seidel-Morgenstern, A., Schmidt-Traub, H., and Guiochon, G. (2001) Effect of the homogeneity of the column set on the performance of a simulated moving bed unit. I. Theory. J. Chromatogr. A, 908, 49-70.
-
(2001)
J. Chromatogr. A
, vol.908
, pp. 49-70
-
-
Mihlbachler, K.1
Fricke, J.2
Yun, T.3
Seidel-Morgenstern, A.4
Schmidt-Traub, H.5
Guiochon, G.6
-
15
-
-
0037168989
-
Effect of the homogeneity of the column set on the performance of a simulated moving bed unit. II. Experimental study
-
Mihlbachler, K., Jupke, A., Seidel-Morgenstern, A., Schmidt-Traub, H., and Guiochon, G. (2002) Effect of the homogeneity of the column set on the performance of a simulated moving bed unit. II. Experimental study. J. Chromatogr. A, 977, 3-22.
-
(2002)
J. Chromatogr. A
, vol.977
, pp. 3-22
-
-
Mihlbachler, K.1
Jupke, A.2
Seidel-Morgenstern, A.3
Schmidt-Traub, H.4
Guiochon, G.5
-
16
-
-
84949051193
-
-
PREP Conference, Boston, July 2013
-
Bisschops, M., Schwan, P., and Lobedann, M. (2013) Membrane adsorbers in a multicolumn chromatography configuration as a viable option for capture chromatography. PREP Conference, Boston, July 2013.
-
(2013)
Membrane adsorbers in a multicolumn chromatography configuration as a viable option for capture chromatography
-
-
Bisschops, M.1
Schwan, P.2
Lobedann, M.3
-
18
-
-
84863548879
-
Biotech facilities average a batch failure every 40.6 weeks
-
Langer, E. (2008) Biotech facilities average a batch failure every 40.6 weeks. Bioprocess Int., 6 (8), 28-29.
-
(2008)
Bioprocess Int.
, vol.6
, Issue.8
, pp. 28-29
-
-
Langer, E.1
-
19
-
-
84949051194
-
Biomanufacturing shows signs of maturity, PAT adoption
-
June 5, 2012
-
Langer, E. (2012) Biomanufacturing shows signs of maturity, PAT adoption. Pharmaceutical Manufacturing, June 5, 2012.
-
(2012)
Pharmaceutical Manufacturing
-
-
Langer, E.1
|